About Kobo Biotech Ltd
Kobo Biotech is primarily engaged in the business of manufacturing Active Pharmaceutical Ingredients (API) based on Fermentation technology.
Founded
1993
CEO
Ajit Kamath
Employees
0
HQ
Mumbai, India
Finished Products
No finished products reported
This company hasn’t disclosed any finished products breakdown.
Raw Materials
No raw materials reported
This company hasn’t disclosed any raw materials breakdown.
About Kobo Biotech Ltd
Kobo Biotech is primarily engaged in the business of manufacturing Active Pharmaceutical Ingredients (API) based on Fermentation technology.
Founded:1993
CEO:Ajit Kamath
Employees:0
HQ:Mumbai, India
Finished Products
No finished products reported
This company hasn’t disclosed any finished products breakdown.
Raw Materials
No raw materials reported
This company hasn’t disclosed any raw materials breakdown.
Price Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹10
52W Low
₹2
Volume738
Avg VolumeN/A
Beta0.61
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-2.40x
Valuation
P/B Ratio
N/A
Valuation
EPS
₹-2.20
Valuation
Dividend Yield
0.00%
Valuation
ROE
3.71%
Profitability
ROCE
-72.69%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
53.2%
International
46.8%
Domestic53.2%
Exports46.8%
Strategic Relations
Collaborations, joint ventures & subsidiaries
X
Xytel Technologies Partnership
United States
0.00% stakeS
Shangai Pengpu Chemical Works
China
0.00% stakeM
M/s SMEC
China
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
-1.05x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-36.5%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.